How much funding has Paratus Sciences raised?

Paratus Sciences has raised $102.5M in total funding, most recently a Pre-Seed round.

Who are Paratus Sciences's investors?

Paratus Sciences's investors include Jessica Lin, Polaris Partners, ARCH Venture Partners, Bling Capital, Teamworthy Ventures, ClavystBio.

When was Paratus Sciences founded?

Paratus Sciences was founded in 2023.

Where is Paratus Sciences headquartered?

Paratus Sciences is headquartered in New York, New York, United States.

What industry is Paratus Sciences in?

Paratus Sciences operates in Biotech, Life Sciences.

How many employees does Paratus Sciences have?

Paratus Sciences has 11-50 employees.

Paratus Sciences

Decoding the evolutionary secrets of bats

New York, United States · Founded 2023 · $102.5M raised

Biotech

Life Sciences

Headquarters: New York, New York
Employees: 11–50
Founded: 2023
Business Model: B2B

Website: paratussciences.com
Total Funding: $102.5M
Last Round: $2.5M Pre-SeedJul 2025
Rounds: 2

About

Paratus Sciences is a biopharmaceutical company that decodes evolutionary biology to discover first-in-class medicines for serious diseases. The company integrates evolutionary insights from species like bats, AI-powered discovery, and multi-omic data to identify novel drug targets, with its lead program PS-1001—a pan-inflammasome inhibitor—advancing toward first-in-human studies in cardiometabolic and inflammatory diseases. It is headquartered in Boston with research operations in Singapore.

Summary

Paratus Sciences is a Biotech company based in New York, United States, founded in 2023. It has raised $102.5M in total across 2 rounds, most recently a $2.5M Pre-Seed round in Jul 2025. Investors include Jessica Lin, Polaris Partners and ARCH Venture Partners.